# FDA Inspection 1166238 - Sea Pearl East Inc. - March 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/6eb4df8a-e8d7-4316-a99f-4baad03506ba
Source feed: FDA_Inspections

> FDA Inspection 1166238 for Sea Pearl East Inc. on March 24, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166238
- Company Name: Sea Pearl East Inc.
- Inspection Date: 2022-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1166238 - 2022-03-24](https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/819fd37a-19b7-470d-87ce-a4af20a9cb5f)
- [FDA Inspection 997614 - 2017-01-19](https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/a4c742b7-b2c4-45e6-a374-95ed2c36ca40)
- [FDA Inspection 899294 - 2014-10-08](https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/d0e2e250-1893-4cf2-ba3f-81630dfb5840)
- [FDA Inspection 846550 - 2013-08-30](https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/2d5a30b9-3382-4d5c-afe4-a2d259478437)
- [FDA Inspection 760010 - 2011-12-21](https://www.keypedia.com/records/fda_inspections/sea-pearl-east-inc/811d33d5-b103-4b2c-80f1-1e3333adc837)

Company: https://www.keypedia.com/companies/sea-pearl-east-inc/fb1e2a1d-c5ef-41c9-bad1-b49aa57c4bff

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d